Clinical TrialMay 21, 2026, 04:28 PM
Apyx Medical Study Shows Significant Cellulite & Skin Laxity Improvement
AI Summary
Apyx Medical Corporation announced the publication of new clinical data in Aesthetic Surgery Journal Open Forum. The study highlights a promising approach to improving cellulite and skin laxity using a combination treatment of Avéli for targeted subcision and Renuvion for skin laxity. Results at 180 days post-treatment showed up to 81.8% of patients improved in cellulite appearance, with objective 3D imaging demonstrating measurable reductions in dimple volume, surface area, and depth. Histological analysis also showed increases in collagen and elastin, indicating progressive tissue remodeling.
Key Highlights
- New clinical data published in Aesthetic Surgery Journal Open Forum.
- Study evaluated combined Avéli and Renuvion treatment for cellulite and skin laxity.
- Up to 81.8% of patients showed improvement in cellulite appearance at 180 days.
- Objective 3D imaging demonstrated measurable reductions in dimple volume, surface area, and depth.
- Histological analysis revealed increased collagen and elastin through 180 days post-treatment.
- The study involved 22 patients receiving a single treatment session.
Price Impact
More from APYX